Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Hung currently holds 1,995,012 shares of NovoCure Ltd (NVCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Hung has been a net seller of NVCR stock. They have purchased $10.0M and sold $73.6M worth of shares.
David Hung's most recent insider trade was on Feb 27, 2026, when they sold 1,995,012 shares at $0.00 per share.
David Hung serves as Executive at NovoCure Ltd (NVCR). They have executed 100 insider transactions totaling $83.6M over their tenure at the company.
David Hung holds the position of Executive at NovoCure Ltd, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
David Hung has shown a selling trading pattern, with $10.0M in total purchases and $73.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Hung was on Feb 10, 2021, when they purchased $20.0M worth of NUVB shares. This transaction involved 2,000,000 shares at $10.00 per share.
David Hung currently owns 1,995,012 shares of NovoCure Ltd (NVCR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Hung's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Hung has 100 Form 4 filings on record as an insider at NovoCure Ltd.
Set alerts for David Hung and 40,000+ other insiders.